RXRX- Recursion Pharmaceuticals, Inc.

Name: Recursion Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 11 buys and 16 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Borgeson Blake	6.65M	$21.01M	-
Dir	Gibson Christopher	4.52M	$14.29M	-
CEO	Khan Najat	2.26M	$7.15M	-
Dir	Li Dean Y	1.24M	$3.92M	-
Other	Hallett David	1.11M	$3.50M	-

Activity

Buys and sells only

Transactions

10 filings · page 17

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 17, 2023	Virani Shafique70	Chief Business Officer	Sale+OE	10,000	$9.16	$91,561.00	-12.0%	-31.7%	+11.8%
Jan 10, 2023	Borgeson Blake69	Director	Sell	8,885	$7.69	$68,283.00	-0.1%	-16.3%	+60.3%
Jan 10, 2023	Mubadala Investment Co Pjsc62	10% Owner	Buy	1,029,795	$7.50	$7,725,856.82	+0.8%	-16.3%	+60.3%
Jan 5, 2023	Gibson Christopher70	Chief Executive Officer	Sell	21,000	$7.39	$155,131.10	-3.8%	-12.5%	+61.9%
Dec 29, 2022	Larson Tina Marriott73	President And COO	Sale+OE	8,000	$7.70	$61,566.40	-3.8%	-12.0%	+28.6%
Dec 27, 2022	Borgeson Blake69	Director	Sell	8,885	$7.25	$64,372.71	-0.1%	-6.1%	+49.4%
Dec 15, 2022	Virani Shafique70	Chief Business Officer	Sale+OE	10,000	$8.85	$88,525.00	-11.3%	-11.7%	+14.5%
Dec 13, 2022	Borgeson Blake69	Director	Sell	8,885	$8.96	$79,598.05	-0.1%	-13.3%	-5.9%
Dec 1, 2022	Gibson Christopher70	Chief Executive Officer	Sale+OE	39,710	$9.04	$358,946.95	-3.3%	-14.5%	-20.5%
Nov 29, 2022	Borgeson Blake69	Director	Sell	8,885	$8.75	$77,785.51	-0.1%	-12.8%	-20.3%

← PrevPage 17Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC